Event Summary

Today, 12/12/25, Fermi (FRMI)’s price fell 33%, falling from roughly $15 to $10 per share, eliminating an estimated $5 billion in market capitalization in a single session. This decline followed a prolonged period of extreme valuation despite the absence of operating revenues or earnings.

By Raymond M. Mullaney
December 12, 2025

Chart 2 shows ERS’s Performance & Risk Chart™ (PRC™) output for Fermi as of October 13, 2025, when the stock traded at $30.01 per share. At that time, ERS’s nine proprietary risk ratings—each independently scaled from +150 (best) to −250 (worst)—produced a combined score of −2,224, only 26 points from the worst possible aggregate rating.

Chart 2 shows ERS’s Performance & Risk Chart™ (PRC™) output for Fermi as of October 13, 2025, when the stock traded at $30.01 per share. At that time, ERS’s nine proprietary risk ratings—each independently scaled from +150 (best) to −250 (worst)—produced a combined score of −2,224, only 26 points from the worst possible aggregate rating.

Chart 3 shows the most recent PRC™ output prior to the decline. Two ratings (PRI and eLiquidity) are not shown due to data-availability issues at the time of publication; this omission does not materially affect the conclusions. 

Financial Facts at the Time of Peak Valuation

At approximately $30 per share, Fermi’s implied valuation was roughly $18 billion.

  • Revenues: $0
  • Net income: $0
  • Cash & short-term investments: approximately $300 million
  • Liabilities: approximately $200 million
  • Source of cash: almost entirely from shareholder capital

Risk Definition Applied

Risk is defined as the probability and magnitude of loss. The combination of no revenues, no earnings, material liabilities, and a multi-billion-dollar market capitalization constituted an extraordinary level of downside exposure.

Fiduciary Suitability Considerations

A fiduciary is required to assess whether an investment is reasonable at the price paid. Absent revenues, earnings, or demonstrable cash-generation capacity, price becomes arbitrary and suitability difficult to substantiate.

What the ERS Ratings Demonstrated

ERS’s ratings quantified the severity of downside risk well in advance. The PRC™ showed near-maximum negative readings across valuation, financial strength, durability, and price-risk dimensions.

Structural Implications

This case illustrates how securities can achieve large valuations without reference to operating fundamentals, exposing investors to sudden and severe losses.

Key Takeaways

  • Large losses can occur when valuation is untethered from financial reality
  • Downside risk is measurable
  • Fiduciary duty requires price-based risk assessment
  • Independent risk analytics improve decision quality

Closing Note

If you’d like to learn more about ratings for your stocks, contact us today.